Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial

BACKGROUND: Despite the heightened risk of serious influenza during infancy, vaccination is not recommended in infants younger than 6 months. We aimed to assess the safety, immunogenicity, and efficacy of maternal immunisation with trivalent inactivated influenza vaccine for protection of infants ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapia, Milagritos D, Sow, Samba O, Tamboura, Boubou, Tégueté, Ibrahima, Pasetti, Marcela F, Kodio, Mamoudou, Onwuchekwa, Uma, Tennant, Sharon M, Blackwelder, William C, Coulibaly, Flanon, Traoré, Awa, Keita, Adama Mamby, Haidara, Fadima Cheick, Diallo, Fatoumata, Doumbia, Moussa, Sanogo, Doh, DeMatt, Ellen, Schluterman, Nicholas H, Buchwald, Andrea, Kotloff, Karen L, Chen, Wilbur H, Orenstein, Evan W, Orenstein, Lauren A V, Villanueva, Julie, Bresee, Joseph, Treanor, John, Levine, Myron M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985566/
https://www.ncbi.nlm.nih.gov/pubmed/27261067
http://dx.doi.org/10.1016/S1473-3099(16)30054-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985566/
https://www.ncbi.nlm.nih.gov/pubmed/27261067
http://dx.doi.org/10.1016/S1473-3099(16)30054-8

Ejemplares similares